Did CNN Just Say the Quiet Part Out Loud About Don Lemon's Arrest?
Democrats Claim Trump Administration Will Use ICE as Voter Suppression Tool
A Federal Judge Just Ruled on Whether Luigi Mangione Will Face the Death...
We Know Who Might Be Funding Those Anti-ICE Protests in Minneapolis
Here's How Senator Warnock Described the Alex Pretti Vigil
Another Leftist Nurse Can No Longer Practice in Florida
Church Mob Suspect Says Being Handcuffed Was ‘Closest I’ve Felt to Slavery’
Actress Catherine O'Hara Dead at 71
Rep. Greg Steube Moves to Expel Democrat Sheila Cherfilus McCormick Following Ethics Probe
Jacob Frey Draws Attention With Remarks at U.S. Conference of Mayors
Centers for Medicare & Medicaid Services Just Closed a Major Tax Loophole
When Life Gives You Lemons: White House Taunts Don Lemon Following His Arrest
Rubio Blasts Dem Senator As She Asks If Trump Will Follow the Geneva...
Bad News for Gov. Tim Walz: Trump Says He Hasn’t Forgotten About Minnesota’s...
Trump Slams Alex Pretti As ‘Agitator’ and 'Insurrectionist' After Watching Resurfaced Vide...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos